Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

4.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.0K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

592
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
592
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.7K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

869
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
869
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.6K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Assessment of the change over time of serum matrix metalloproteinases and vascular endothelial growth factor in the acute period of ischemic stroke].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Neuroinflammatory and neurodegenerative aspects of Parkinson's disease].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Difficulties in lifetime diagnosis of Creutzfeldt-Jakob disease].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2024
Same author

[Association of inflammation and chronic fatigue syndrome in patients with Parkinson's disease].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2024

Related Experiment Video

Updated: Apr 16, 2026

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

3.5K

[Moyamoya disease].

K I Burkova1, M N Azhermacheva2, V M Alifirova2

  • 1Regional'nyĭ sosudistyĭ tsentr dlia lecheniia ostrykh narusheniĭ mozgovogo krovoobrashcheniia OGAUZ 'Tomskaia oblastnaia klinicheskaia bol'nitsa', Tomsk.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|March 3, 2015
PubMed
Summary
This summary is machine-generated.

Moyamoya disease, a rare brain vessel condition, involves artery constriction and a characteristic "puff of smoke" appearance on imaging. This case highlights its occurrence in a 27-year-old from Tomsk presenting with stroke symptoms.

More Related Videos

Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
09:11

Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability

Published on: February 23, 2016

23.4K
Permanent Cerebral Vessel Occlusion via Double Ligature and Transection
08:22

Permanent Cerebral Vessel Occlusion via Double Ligature and Transection

Published on: July 21, 2013

15.8K

Related Experiment Videos

Last Updated: Apr 16, 2026

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

3.5K
Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
09:11

Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability

Published on: February 23, 2016

23.4K
Permanent Cerebral Vessel Occlusion via Double Ligature and Transection
08:22

Permanent Cerebral Vessel Occlusion via Double Ligature and Transection

Published on: July 21, 2013

15.8K

Area of Science:

  • Neurology
  • Vascular Neurology
  • Radiology

Background:

  • Moyamoya syndrome is a rare, progressive cerebrovascular disease characterized by stenosis of the internal carotid arteries and the circle of Willis.
  • It leads to the development of fragile collateral vessels, often described as a 'puff of smoke' on angiography, to compensate for blocked arteries.

Observation:

  • A clinical case of Moyamoya disease in a 27-year-old patient from Tomsk is presented.
  • The patient experienced an acute stroke affecting the right middle cerebral artery.
  • Clinical manifestations included dysarthria and paralysis of the VII and XII cranial nerves.

Findings:

  • Magnetic Resonance Imaging (MRI)-angiogram results were crucial in suggesting the diagnosis of Moyamoya disease.
  • The findings were consistent with established diagnostic criteria for Moyamoya syndrome.
  • The case underscores the potential for Moyamoya disease to manifest in diverse geographical locations.

Implications:

  • This case contributes to the understanding of Moyamoya disease's presentation and diagnosis in non-Japanese populations.
  • Early diagnosis through advanced imaging like MRI-angiography is vital for timely intervention.
  • Further research into the geographical distribution and clinical variations of Moyamoya disease is warranted.